[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
An Entity of Type: Listed company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is an innovation and R&D-driven pharmaceutical company with a mission of “providing today’s patients with medicines of the future.” It has established a National Key Laboratory of Translational Medicine and Innovative Drug Development. The company focuses on three therapeutic areas including oncology, central nervous system and autoimmune diseases with forward-looking layout of disease areas that may have significant clinical needs in the future. Leveraging its R&D capability and commercialization excellence, Simcere has built a market-leading product portfolio in China. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading innovati

Property Value
dbo:abstract
  • Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is an innovation and R&D-driven pharmaceutical company with a mission of “providing today’s patients with medicines of the future.” It has established a National Key Laboratory of Translational Medicine and Innovative Drug Development. The company focuses on three therapeutic areas including oncology, central nervous system and autoimmune diseases with forward-looking layout of disease areas that may have significant clinical needs in the future. Leveraging its R&D capability and commercialization excellence, Simcere has built a market-leading product portfolio in China. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading innovative companies and research institutes. The company has been continuously recognized as one of the “Top Innovative Pharmaceutical Enterprises in China” and “Top 100 Pharmaceutical Manufacturing Enterprises of China”. (en)
dbo:industry
dbo:numberOfEmployees
  • 6100 (xsd:nonNegativeInteger)
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 20209989 (xsd:integer)
dbo:wikiPageLength
  • 17757 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1115435325 (xsd:integer)
dbo:wikiPageWikiLink
dbp:homepage
dbp:industry
dbp:locationCity
dbp:locationCountry
  • China (en)
dbp:name
  • Simcere Pharmaceutical Group (en)
dbp:numEmployees
  • 6100 (xsd:integer)
dbp:revenue
dbp:type
  • Listed, SEHK:2096 (en)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is an innovation and R&D-driven pharmaceutical company with a mission of “providing today’s patients with medicines of the future.” It has established a National Key Laboratory of Translational Medicine and Innovative Drug Development. The company focuses on three therapeutic areas including oncology, central nervous system and autoimmune diseases with forward-looking layout of disease areas that may have significant clinical needs in the future. Leveraging its R&D capability and commercialization excellence, Simcere has built a market-leading product portfolio in China. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading innovati (en)
rdfs:label
  • Simcere Pharmaceutical (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Simcere Pharmaceutical Group (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License